Question 1

What is Synnovis?

Accepted Answer

Synnovis is a Entity.

Question 2

How often does Synnovis appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Synnovis first tracked by Ergen?

Accepted Answer

First tracked on May 13, 2026.

Question 4

When was Synnovis last mentioned in news?

Accepted Answer

Last active on May 13, 2026.

Question 5

What is Synnovis's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Synnovis in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Synnovis?

Accepted Answer

SOPHiA GENETICS, Synnovis Partner for UK Cancer Testing (May 13, 2026, 7 articles).

Question 8

How did the "SOPHiA GENETICS, Synnovis Partner for UK Cancer Testing" event impact Synnovis?

Accepted Answer

Synnovis partnered with Sophia Genetics to bring liquid biopsy testing to lung and breast cancer patients across the United Kingdom, enhancing its pathology services and supporting Bret Engemann's 'blood test-first' program.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.